Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Tuberculosis

Free Subscription Articles published in J Infect Retrieve available abstracts of 54 articles: HTML format

Single Articles

August 2026
1. BOLOKO L, Schutz C, Ward A, Wilkinson RJ, et al
   Mycobacterium tuberculosis pathogen load and associated inflammatory responses define infection severity in HIV-associated TB and interact with age to predict mortality.
   J Infect. 2026 Aug 8:106828. doi: 10.1016/j.jinf.2026.106828.
   PubMed     Abstract available
   
   
   
2. ZHANG S, Qi J, Zheng J, Qin Y, et al
   National and subnational burden of HIV-negative MDR-TB in China, 1990-2023: Spatio-temporal heterogeneity, long-term trends, and projections.
   J Infect. 2026;93:106816.
   PubMed     Abstract available
   
   
   
3. DONOVAN J, Hung TT, Hiep NTT, Nghia HDT, et al
   A randomised comparison of management strategies for drug-induced liver injury associated with tuberculous meningitis treatment.
   J Infect. 2026;93:106796.
   PubMed     Abstract available
   
   
   July 2026
4. DONOVAN J, Thanh NT, Ngoc LHB, Hanh NHH, et al
   The cause, treatment and outcome of hyponatraemia associated with tuberculous meningitis: An observational study nested within two clinical trials of corticosteroids.
   J Infect. 2026;93:106763.
   PubMed     Abstract available
   
   
   June 2026
5. CARTER EC, Fernandez C, Lim C, Bharucha T, et al
   Incidence, risk factors and management of paradoxical reaction in central nervous system tuberculosis in the United Kingdom.
   J Infect. 2026 Jun 3:106778. doi: 10.1016/j.jinf.2026.106778.
   PubMed     Abstract available
   
   
   
6. JAMESON G, Batten I, Dyer AH, Geoghegan C, et al
   Monocyte metabolic plasticity and cytokine production differentiate latent TB infection from active disease.
   J Infect. 2026;92:106755.
   PubMed     Abstract available
   
   
   May 2026
7. MADDEN AE, Huang CC, Calderon RI, Lecca L, et al
   Prevalence and clinical implications of Aspergillus infection among tuberculosis patients in Peru.
   J Infect. 2026;93:106767.
   PubMed     Abstract available
   
   
   
8. MARTINEZ-CAMPRECIOS J, Aznar ML, Zacarias A, Teran R, et al
   Corrigendum to "A non-randomized pragmatic historically controlled trial evaluating the effectiveness and safety of a bedaquiline or a linezolid-based short regimen for rifampicin-resistant tuberculosis".
   J Infect. 2026;92:106752.
   PubMed    
   
   
   
9. ZHANG S, Qi J, Zheng J, Qin Y, et al
   National and subnational burden of XDR-TB in China, 1990-2023: Long-term trends, regional disparities, and projections, 2024-2050.
   J Infect. 2026;92:106728.
   PubMed     Abstract available
   
   
   February 2026
10. SHAN QQ, Luo M, Zhang Y, Tang D, et al
    ANKRD22 as a Novel Diagnostic Biomarker and Immunomodulator in Tuberculosis Disease: A Multi-Cohort and Clinical Validation Study.
    J Infect. 2026 Feb 15:106703. doi: 10.1016/j.jinf.2026.106703.
    PubMed     Abstract available
    
    
    January 2026
11. SUN L, Fang M, Chen Y, Jiao W, et al
    A blood-based Xpert host response assay for diagnosis and differentiation of active and latent tuberculosis in children and adolescents: a multi-center, prospective study.
    J Infect. 2026 Jan 12:106678. doi: 10.1016/j.jinf.2026.106678.
    PubMed     Abstract available
    
    
    December 2025
12. HARARIYA K, Singh TR, Kalra A, Padhi S, et al
    Comment on "Tuberculosis incidence in solid organ transplant recipients in Europe: A multicenter TBnet cohort study".
    J Infect. 2025 Dec 27:106670. doi: 10.1016/j.jinf.2025.106670.
    PubMed    
    
    
    
13. LANGE B, Brehm TT, Arend SM, Arias-Guillen M, et al
    Tuberculosis incidence in solid organ transplant recipients in Europe: A multicenter TBnet cohort study.
    J Infect. 2025;92:106668.
    PubMed     Abstract available
    
    
    November 2025
14. PICHLO S, Carballo PS, Reimann M, Zielinski N, et al
    Lipoarabinomannan (LAM) for the diagnosis of tuberculosis from sputum.
    J Infect. 2025 Nov 18:106662. doi: 10.1016/j.jinf.2025.106662.
    PubMed    
    
    
    October 2025
15. ZHANG Y, Li D, Liu J, Jiang Y, et al
    Association between pre-diagnostic fluoroquinolone exposure and possible acquired fluoroquinolone resistance in Mycobacterium tuberculosis in Shanghai: an EHR-based case-control study using whole-genome sequencing.
    J Infect. 2025 Oct 31:106648. doi: 10.1016/j.jinf.2025.106648.
    PubMed     Abstract available
    
    
    September 2025
16. SONG C, Zhao CY, Qiang HB, Huang XW, et al
    Detection of Pulmonary Tuberculosis and Drug Resistance in Sputum Samples Using Targeted Next-Generation Sequencing.
    J Infect. 2025 Sep 30:106621. doi: 10.1016/j.jinf.2025.106621.
    PubMed    
    
    
    August 2025
17. TIAN N, Li P, Ju D, Lai S, et al
    The real-world performance of a novel interferon gamma release assay based on fluorescence immunochromatography in detecting Mycobacterium tuberculosis infection in South China.
    J Infect. 2025;91:106605.
    PubMed    
    
    
    June 2025
18. ZHAO CY, Song C, Jiang CY, Liu RH, et al
    Large Language Models (LLMs) in Tuberculosis Patients' Health Consultation and Patient Education: A Comprehensive Performance Analysis Study.
    J Infect. 2025 Jun 2:106527. doi: 10.1016/j.jinf.2025.106527.
    PubMed    
    
    
    May 2025
19. SONNENKALB L, Trubenova B, Regoes RR, Merker M, et al
    The mutant selection window of moxifloxacin and bedaquiline resistant Mycobacterium tuberculosis.
    J Infect. 2025 May 30:106523. doi: 10.1016/j.jinf.2025.106523.
    PubMed     Abstract available
    
    
    
20. WANG Y, Ma Z, Liu Z, Dong X, et al
    Tongue swab-based molecular diagnostics for pulmonary tuberculosis and drug resistance in adults: A prospective multicenter diagnostic accuracy study.
    J Infect. 2025;91:106517.
    PubMed     Abstract available
    
    
    
21. DANIEL BD, Shanmugam S, Mehta R, Bhalla M, et al
    Long term outcomes in drug resistant tuberculosis with Bedaquiline, Pretomanid and varying doses of Linezolid.
    J Infect. 2025 May 15:106509. doi: 10.1016/j.jinf.2025.106509.
    PubMed     Abstract available
    
    
    April 2025
22. MAGODORO IM, Wilkinson KA, Claggett BL, Ntusi NAB, et al
    Discordance between measures of Mycobacterium tuberculosis sensitization and type 2 diabetes mellitus in the United States (NHANES): A population-based cohort study.
    J Infect. 2025;90:106496.
    PubMed     Abstract available
    
    
    February 2025
23. WANG X, Jiang K, Xing W, Xin Q, et al
    Clustering Mycobacterium tuberculosis-specific CD154(+)CD4(+) T cells for distinguishing tuberculosis disease from infection based on single-cell RNA-seq analysis.
    J Infect. 2025;90:106449.
    PubMed     Abstract available
    
    
    January 2025
24. ZHANG K, Xu Y, Li Z, Cai Y, et al
    Elevated PD-1 and PDL-1 autoantibodies and association with tuberculosis.
    J Infect. 2025 Jan 25:106430. doi: 10.1016/j.jinf.2025.106430.
    PubMed    
    
    
    
25. MAPAMBA DA, Sabi I, Lalashowi J, Sauli E, et al
    N-acetylcysteine modulates markers of oxidation, inflammation and infection in tuberculosis.
    J Infect. 2025 Jan 3:106379. doi: 10.1016/j.jinf.2024.106379.
    PubMed     Abstract available
    
    
    
26. LI L, Mao L, van der Zalm MM, Olivo J, et al
    Blood-based diagnosis of pediatric tuberculosis: a prospective cohort study in South Africa and Dominican Republic.
    J Infect. 2025 Jan 2:106404. doi: 10.1016/j.jinf.2024.106404.
    PubMed     Abstract available
    
    
    December 2024
27. NEUMANN M, Reimann M, Chesov D, Popa C, et al
    The Molecular Bacterial Load Assay predicts treatment responses in patients with pre-XDR/XDR-tuberculosis more accurately than GeneXpert Ultra MTB/Rif.
    J Infect. 2024 Dec 27:106399. doi: 10.1016/j.jinf.2024.106399.
    PubMed     Abstract available
    
    
    
28. ZHANG H, Chen Y, Chen R, Ning Y, et al
    Hemophagocytic lymphohistiocytosis is associated with disseminated tuberculosis in patients with advanced HIV infection.
    J Infect. 2024 Dec 23:106384. doi: 10.1016/j.jinf.2024.106384.
    PubMed    
    
    
    November 2024
29. AHOR HS, Vivekanandan MM, Adankwah E, Minadzi D, et al
    Monocyte transcriptome signatures of inflammation and enhanced neutrophil recruitment characterize immunopathology in the blood of tuberculosis patients.
    J Infect. 2024;89:106359.
    PubMed     Abstract available
    
    
    October 2024
30. KUMAR NP, Balaji S, Devi PG, Ramraj B, et al
    Inflammatory Cytokine Responses in Pediatric tuberculosis with or without SARS-CoV-2 seropositivity.
    J Infect. 2024 Oct 17:106314. doi: 10.1016/j.jinf.2024.106314.
    PubMed     Abstract available
    
    
    
31. MARTINEZ-CAMPRECIOS J, Aznar ML, Zacarias A, Teran R, et al
    A non-randomized pragmatic historically controlled trial evaluating the effectiveness and safety of a bedaquiline or a linezolid-based short regimen for rifampicin-resistant tuberculosis.
    J Infect. 2024 Oct 17:106291. doi: 10.1016/j.jinf.2024.106291.
    PubMed     Abstract available
    
    
    September 2024
32. PETRONE L, Peruzzu D, Altera AMG, Salmi A, et al
    Therapy modulates the response to T cell epitopes over the spectrum of tuberculosis infection.
    J Infect. 2024 Sep 27:106295. doi: 10.1016/j.jinf.2024.106295.
    PubMed     Abstract available
    
    
    July 2024
33. JIANG J, Cao Z, Li B, Ma X, et al
    Disseminated tuberculosis is associated with impaired T cell immunity mediated by non-canonical NF-kappaB pathway.
    J Infect. 2024;89:106231.
    PubMed     Abstract available
    
    
    
34. ZHU X, Pan X, Da M, Wang F, et al
    Risk for latent tuberculosis infection reactivation among patients with psoriasis on biologics treatment: A meta-analysis.
    J Infect. 2024 Jul 8:106226. doi: 10.1016/j.jinf.2024.106226.
    PubMed    
    
    
    June 2024
35. AKALU TY, Clements ACA, Gebreyohannes EA, Gilmour B, et al
    Prevalence of tuberculosis infection among contacts of drug-resistant tuberculosis patients: A systematic review and meta-analysis.
    J Infect. 2024 Jun 19:106198. doi: 10.1016/j.jinf.2024.106198.
    PubMed     Abstract available
    
    
    
36. VAN ARKEL C, Storms I, Kurver L, Smeenk F, et al
    Elderly patients with tuberculosis in a low-incidence country - clinical characteristics, inflammation and outcome.
    J Infect. 2024 Jun 18:106200. doi: 10.1016/j.jinf.2024.106200.
    PubMed     Abstract available
    
    
    
37. AUDRAN R, Karoui O, Donnet L, Soumas V, et al
    Randomized, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route.
    J Infect. 2024 Jun 17:106205. doi: 10.1016/j.jinf.2024.106205.
    PubMed     Abstract available
    
    
    
38. OSMAN R, Dema E, David A, Hughes G, et al
    Understanding the potential role of whole genome sequencing (WGS) in managing patients with gonorrhoea: A systematic review of WGS use on human pathogens in individual patient care.
    J Infect. 2024;88:106168.
    PubMed     Abstract available
    
    
    May 2024
39. MUTAVHATSINDI H, Manyelo CM, Snyders CI, Van Rensburg I, et al
    Baseline and end-of-treatment host serum biomarkers predict relapse in adults with pulmonary tuberculosis.
    J Infect. 2024;89:106173.
    PubMed     Abstract available
    
    
    
40. WAGNEW F, Alene KA, Kelly M, Gray D, et al
    Undernutrition increases the risk of unsuccessful treatment outcomes of patients with tuberculosis in Ethiopia: A multicenter retrospective cohort study.
    J Infect. 2024;89:106175.
    PubMed     Abstract available
    
    
    April 2024
41. WEN Z, Wang L, Ma H, Li L, et al
    Integrated single-cell transcriptome and T cell receptor profiling reveals defects of T cell exhaustion in pulmonary tuberculosis.
    J Infect. 2024 Apr 18:106158. doi: 10.1016/j.jinf.2024.106158.
    PubMed     Abstract available
    
    
    
42. LIANG Q, Jiang X, Jia J, Zhao L, et al
    An early and trustable indicator suggestive of non-tuberculosis mycobacteria isolation in a high Tuberculosis burden setting.
    J Infect. 2024 Apr 2:106149. doi: 10.1016/j.jinf.2024.106149.
    PubMed     Abstract available
    
    
    February 2024
43. BUREL JG, Wang W, Wuhrer M, Dedicoat M, et al
    IgG glycosylation associates with risk of progression from latent to active tuberculosis.
    J Infect. 2024 Feb 1:S0163-4453(24)00033-1. doi: 10.1016/j.jinf.2024.
    PubMed     Abstract available
    
    
    December 2023
44. LONG R, Croxen M, Lee R, Doroshenko A, et al
    The Association between PHYLOGENETIC LINEAGE AND THE SUBCLINICAL Phenotype OF PULMONARY TUBERCULOSIS: A retrospective 2-Cohort study.
    J Infect. 2023 Dec 15:S0163-4453(23)00592-3. doi: 10.1016/j.jinf.2023.
    PubMed     Abstract available
    
    
    
45. LIU Y, Sun R, Zhang H, Huang J, et al
    Trends and predictions of tuberculosis notification in mainland China during and after the COVID-19 pandemic.
    J Infect. 2023;87:e100-e103.
    PubMed    
    
    
    November 2023
46. HUANG Z, Huang H, Hu J, Xia L, et al
    A novel quantitative urine LAM strip for point-of-care tuberculosis diagnosis in non-HIV adults.
    J Infect. 2023 Nov 28:S0163-4453(23)00586-8. doi: 10.1016/j.jinf.2023.
    PubMed    
    
    
    October 2023
47. ZHANG G, Zhang H, Zhang Y, Hu X, et al
    Targeted Next-Generation Sequencing Technology Showed Great Potential in Identifying Spinal Tuberculosis and Predicting the Drug Resistance.
    J Infect. 2023 Oct 26:S0163-4453(23)00549-2. doi: 10.1016/j.jinf.2023.
    PubMed    
    
    
    
48. CHESOV E, Chesov D, Reimann M, Dreyer V, et al
    Impact of Mycobacterium tuberculosis strain type on multidrug-resistant tuberculosis severity, Republic of Moldova.
    J Infect. 2023 Oct 10:S0163-4453(23)00532-7. doi: 10.1016/j.jinf.2023.
    PubMed    
    
    
    September 2023
49. WANG L, Ma H, Wen Z, Niu L, et al
    Single-cell RNA-sequencing reveals heterogeneity and intercellular crosstalk in human tuberculosis lung.
    J Infect. 2023 Sep 8:S0163-4453(23)00506-6. doi: 10.1016/j.jinf.2023.
    PubMed     Abstract available
    
    
    June 2023
50. PEDERSEN OS, Holmgaard FB, Mikkelsen MKD, Lange C, et al
    Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysis.
    J Infect. 2023 Jun 23:S0163-4453(23)00337-7. doi: 10.1016/j.jinf.2023.
    PubMed     Abstract available
    
    
    April 2023
51. MORRISON H, Perrin F, Dedicoat M, Ahmed R, et al
    Impact of COVID-19 on NHS Tuberculosis Services: Results of a UK-wide survey.
    J Infect. 2023 Apr 10:S0163-4453(23)00204-9. doi: 10.1016/j.jinf.2023.
    PubMed    
    
    
    March 2023
52. WANG Y, Sun Q, Zhang Y, Li X, et al
    Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlas.
    J Infect. 2023 Mar 30:S0163-4453(23)00191-3. doi: 10.1016/j.jinf.2023.
    PubMed     Abstract available
    
    
    
53. NAMGUNG SH, Jung J, Kim SK, Kim EO, et al
    Incidence of tuberculosis infection in healthcare workers in high-risk departments for tuberculosis after universal wearing of KF94 mask during COVID-19 pandemic.
    J Infect. 2023 Mar 21:S0163-4453(23)00146-9. doi: 10.1016/j.jinf.2023.
    PubMed    
    
    
    
54. CLARKE J, Moore M, O'Shea MK, Dedicoat M, et al
    Identifying opportunities to improve the microbiological diagnosis of Tuberculosis in a low endemic urban setting.
    J Infect. 2023 Mar 9:S0163-4453(23)00137-8. doi: 10.1016/j.jinf.2023.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum